A global perspective in second‐line treatment patterns for patients with advanced esophageal squamous cell carcinoma
Abstract Background Esophageal cancer is a highly prevalent cancer associated with low survival, especially among those with advanced disease. Second‐line (2L) treatment patterns and related clinical outcomes of patients with advanced esophageal squamous cell carcinoma (advESCC) treated in routine c...
Main Authors: | Dena H. Jaffe, Joseph Gricar, Marc DeCongelio, deMauri S. Mackie |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-05-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14334 |
Similar Items
-
Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy
by: Chia-Hsin Lin, et al.
Published: (2020-03-01) -
Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma
by: Zhang C, et al.
Published: (2024-02-01) -
Drug repositioning for esophageal squamous cell carcinoma
by: Adam N. Bennett, et al.
Published: (2022-09-01) -
Clinical value of station 4R node dissection in esophageal squamous cell carcinoma
by: Xin-ye Wang, et al.
Published: (2023-12-01) -
Global research trend of esophageal squamous cell carcinoma from 2012 to 2022: a bibliometric analysis
by: Zehua Zhang, et al.
Published: (2022-08-01)